SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.07-3.4%Nov 20 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Machaon who wrote (24162)8/7/1998 10:50:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
The Panretin trials have been completed, but Targretin trials have not. When the Targretin trials are completed, both sets of results will be released as well as the selection of which drug will move to a registration track with Phase III trials. I believe that Panretin works, but elevates triglycerides. LGND is looking to see if Targretin will work, without raising triglycerides.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext